Lidi Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lidi Cheng has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Haisu Fan
Department of Anesthesiology, Women's and Children's Hospital of Qingdao University, Qingdao, 266011, China
2 shared publicationsMiaojie Lang
Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, 313000, China
2 shared publicationsSiqi Chen
Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, 313000, China
2 shared publicationsWangchen Yao
Savaid Stomatology School, Hangzhou Medical College, Hangzhou, 310000, China
2 shared publications- Dian Xu
Contribution: Data curation (lead), Formal analysis (equal), Investigation (lead), Writing - original draft (lead), Writing - review & editing (equal)
1 shared publication Dongyang Zhou
The Affiliated Hospital of Qingdao University, Qingdao 266003, China
1 shared publication
Latest Publications
- 23 October 2026
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (6) , 103046
Study on the promotion of healing of rabbit dental extraction wounds after bisphosphonate injection by slow-release bFGF from chitosan hydrogel
- 23 October 2026
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (6) , 103046
Study on the promotion of healing of rabbit dental extraction wounds after bisphosphonate injection by slow-release bFGF from chitosan hydrogel
- Open Access
- 28 March 2026
- Published by Elsevier in SSRN Electronic Journal
Study on the Promotion of Healing of Rabbit Dental Extraction Wounds After Bisphosphonate Injection by Slow-Release bFGF from Chitosan Hydrogel
The growing prevalence of bisphosphonates (BPs) poses a formidable challenge to the treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ), for which effective therapeutic approaches remain scarce to date. This study introduces a chitosan-based thermosensitive composite hydrogel system (CS-bFGF) loaded with basic fibroblast growth factor (bFGF), which is engineered to accelerate the healing of tooth extraction sockets in rabbits following zoledronic acid administration. We conducted a comprehensive characterization of CS-bFGF, with a specific focus on its microstructure. In addition, in vitro assays demonstrated that the prepared CS-bFGF exhibited excellent cytocompatibility. The healing efficacy was evaluated at 3 months post-implantation of CS-bFGF into the tooth extraction sockets of zoledronic acid-treated rabbits. Gross examination and histological assessments revealed that the presence of CS-bFGF led to a significant reduction in total osteonecrosis and inflammatory infiltration in the BRONJ animal model, with a particularly marked improvement in the formation of new bone. These findings indicate that CS-bFGF holds substantial potential as a therapeutic agent for the management of BRONJ.
- 28 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessStudy on the Promotion of Healing of Rabbit Dental Extraction Wounds After Bisphosphonate Injection by Slow-Release bFGF from Chitosan Hydrogel
The growing prevalence of bisphosphonates (BPs) poses a formidable challenge to the treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ), for which effective therapeutic approaches remain scarce to date. This study introduces a chitosan-based thermosensitive composite hydrogel system (CS-bFGF) loaded with basic fibroblast growth factor (bFGF), which is engineered to accelerate the healing of tooth extraction sockets in rabbits following zoledronic acid administration. We conducted a comprehensive characterization of CS-bFGF, with a specific focus on its microstructure. In addition, in vitro assays demonstrated that the prepared CS-bFGF exhibited excellent cytocompatibility. The healing efficacy was evaluated at 3 months post-implantation of CS-bFGF into the tooth extraction sockets of zoledronic acid-treated rabbits. Gross examination and histological assessments revealed that the presence of CS-bFGF led to a significant reduction in total osteonecrosis and inflammatory infiltration in the BRONJ animal model, with a particularly marked improvement in the formation of new bone. These findings indicate that CS-bFGF holds substantial potential as a therapeutic agent for the management of BRONJ.
- 27 May 2022
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 4 (6) , 4476-4485
3D-Printed Drug-Loaded Composite Scaffolds to Promote Osteogenesis and Antibacterial Activity
- 27 May 2022
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 4 (6) , 4476-4485
3D-Printed Drug-Loaded Composite Scaffolds to Promote Osteogenesis and Antibacterial Activity